Cardiff Lexington Corporation announced its financial results for the fourth quarter and full year ended December 31, 2024, on March 17, 2025. The company reported a 31% increase in fourth-quarter revenue, reaching $3.1 million.
Gross profit for the fourth quarter increased to $2.0 million, representing 65% of total revenue. For the full year 2024, shareholders' equity saw a 267% increase compared to 2023.
The company also expanded the footprint of its Nova Ortho and Spine subsidiary and enhanced patient volume during 2024. These operational improvements contributed to the reported financial performance.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.